Advertisement

Imaging in Thyroid Cancer

  • Stephen J. Gwyther
Part of the Head and Neck Cancer Clinics book series (HNCC)

Abstract

This chapter summarizes current imaging modalities in thyroid cancer.

Keywords

Thyroid Cancer Thyroid Nodule Core Biopsy Benign Nodule Anaplastic Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. AACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Association Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006;12:63–102Google Scholar
  2. Danese D, Sciacchitano S, Farsetti A, et al. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid 1998;8:15–21.CrossRefPubMedGoogle Scholar
  3. Dahnert W. Radiology review manual. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003:394–6.Google Scholar
  4. Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005;237:794–800.CrossRefPubMedGoogle Scholar
  5. Grunwald F, Kalicke T, Feine U, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study. Eur J Nucl Med 1999;26:1547–52.CrossRefPubMedGoogle Scholar
  6. Horner MJ, Ries LAG, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975–2006. National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission, posted to the SEER website, 2009
  7. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma. Surgery 1993;114:1050–8.PubMedGoogle Scholar
  8. Hoang JK, Lee WK, Lee M, et al. US features of thyroid malignancy: Pearls and pitfalls. RadioGraphics 2007;27:847–60; discussion 861–5.CrossRefPubMedGoogle Scholar
  9. Imaizumi M, Usa T, Tominaga T, et al. Radiation dose–response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55–58 years after radiation exposure. JAMA 2006;295:1011–22.CrossRefPubMedGoogle Scholar
  10. Jun P, Chow LC, Jeffrey RB. The sonographic features of papillary thyroid carcinomas: Pictorial essay. Ultrasound Q 2005;21:39–45.PubMedGoogle Scholar
  11. Johnson NA, Tublin ME. Postoperative surveillance of differentiated thyroid cancer: Rationale, techniques and controversies. Radiology 2008;249:429–44.CrossRefPubMedGoogle Scholar
  12. Jeong GY, Marom EM, Munden RF, et al. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer. Radiology 2005;236:271–5.CrossRefGoogle Scholar
  13. Kessler A, Rappaport Y, Blank A, et al. Cystic appearance of cervical lymph nodes is characteristic of metastatic papillary thyroid carcinoma. J Clin Ultrasound 2003;31:21–5.CrossRefPubMedGoogle Scholar
  14. Kim MJ, Kim E-K, Park SI, et al. US-guided fine-needle aspiration of thyroid nodules: Indications, techniques, results. RadioGraphics 2008;28:1869–86.CrossRefPubMedGoogle Scholar
  15. Kwak JY, Kim E-K, Yun M, et al. Thyroid incidentalomas identified by 18F-FDG PET: Sonographic correlation. Am J Roentgenol 2008;191:598–603.CrossRefGoogle Scholar
  16. Kim EK, Park CS, Chung WY, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol 2002;178:687–91.CrossRefPubMedGoogle Scholar
  17. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002;87:1941–6.CrossRefPubMedGoogle Scholar
  18. Pacini F, Molinaro E, Castagna MG, et al. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003;88:3668–73.CrossRefPubMedGoogle Scholar
  19. Shammas A, Degirmenci B, Mountz JM, et al. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer. J Nucl Med 2007;48:221–6.PubMedGoogle Scholar

Copyright information

© The Author(s) 2012

Authors and Affiliations

  1. 1.Department of RadiologyEast Surrey HospitalRedhillUK

Personalised recommendations